These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 3038422)
21. Effects of converting enzyme inhibition on blood pressure, plasma renin activity (PRA) and plasma aldosterone in hypertensive diabetics compared to patients with essential hypertension. Sullivan PA; Kelleher M; Twomey M; Dineen M J Hypertens; 1985 Aug; 3(4):359-63. PubMed ID: 2995484 [TBL] [Abstract][Full Text] [Related]
22. [Effect of hydrochlorothiazide on various components of the kinin system and plasma renin activity in patients with arterial hypertension treated with captopril]. Kolber-Postepska B; Zebrowska-Lupina I; Markiewicz M; Horubała-Bielak G Wiad Lek; 1992 Aug; 45(15-16):569-74. PubMed ID: 1336910 [TBL] [Abstract][Full Text] [Related]
23. Effects of a single administration of captopril on hemodynamics and serum angiotensin converting enzyme activity, plasma renin activity and plasma aldosterone concentration in hypertensive patients. Hashimoto H; Hiwada K; Kokubu T Jpn Circ J; 1981 Feb; 45(2):176-80. PubMed ID: 6262543 [TBL] [Abstract][Full Text] [Related]
24. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension]. Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470 [TBL] [Abstract][Full Text] [Related]
25. [Effect of a single dose of intravenous captopril in hypertensive subjects]. Franchi M; Puccetti F; Landini F; Burresi A; Di Perri T Recenti Prog Med; 1988 Jun; 79(6):261-6. PubMed ID: 2843976 [No Abstract] [Full Text] [Related]
26. [Usefulness of converting enzyme inhibitors in diagnosis of renovascular hypertension. I. Comparison of the effect of angiotensin converting enzyme inhibition on blood pressure and plasma renin activity in patients with primary hypertension and renovascular hypertension]. Posadzy-Małaczyńska A Przegl Lek; 1997; 54(5):314-9. PubMed ID: 9380805 [TBL] [Abstract][Full Text] [Related]
27. Clinical studies with captopril treatment of hypertensive patients. Varga K; Alföldi S; Kiss I; Simkó K; Farsang C Acta Physiol Hung; 1988; 72 Suppl():67-78. PubMed ID: 2855293 [TBL] [Abstract][Full Text] [Related]
28. Studies on the mechanism of the enhancement of the antihypertensive activity of captopril by a diuretic in spontaneously hypertensive rats. Lai FM; Tanikella T; Herzlinger H; Goldstein B; Chan PS; Cervoni P Clin Exp Hypertens A; 1982; 4(6):1001-18. PubMed ID: 6284411 [TBL] [Abstract][Full Text] [Related]
29. [Hypertensive crisis: comparative study of oral captopril, sublingual captopril and sublingual nifedipine]. Martínez Amenós A; Carratalà J; Pintó X; Santaló M; Tamayo C; Pujol M Med Clin (Barc); 1987 Jun; 89(2):59-61. PubMed ID: 3302561 [No Abstract] [Full Text] [Related]
30. [The changes in renin-angiotensin-aldosterone system in acute myocardial infarction and the effects of converting enzyme inhibitor-captopril]. Jiang M Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec; 19(6):342-4, 396. PubMed ID: 1668233 [TBL] [Abstract][Full Text] [Related]
31. Contribution of angiotensin I converting enzyme gene polymorphism and angiotensinogen gene polymorphism to blood pressure regulation in essential hypertension. Mondorf UF; Russ A; Wiesemann A; Herrero M; Oremek G; Lenz T Am J Hypertens; 1998 Feb; 11(2):174-83. PubMed ID: 9524045 [TBL] [Abstract][Full Text] [Related]
32. Urinary kallikrein excretion can predict the blood pressure response to a single oral dose of captopril. Madeddu P; Oppes M; Rubattu S; Bandiera F; Dessi'-Fulgheri P; Glorioso N; Soro A; Chiara-Troffa M; Rappelli A Agents Actions Suppl; 1987; 22():321-8. PubMed ID: 3324715 [TBL] [Abstract][Full Text] [Related]
33. A paradoxical increase in circulating ACE (angiotensin converting enzyme) activity after long-term administration of alacepril (ACE inhibitor). Nishida S; Matsuki M; Sumitomo S; Kawai Y; Yoneda M Horm Metab Res; 1997 Mar; 29(3):153-4. PubMed ID: 9137988 [No Abstract] [Full Text] [Related]
34. [Sublingual captopril in hypertensive crises]. Alletto M; Burgio A; Fulco G; Paradiso R; Piangiamore M; Vancheri F Recenti Prog Med; 1992 Sep; 83(9):503-5. PubMed ID: 1439119 [TBL] [Abstract][Full Text] [Related]
35. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems. Ohman KP; Karlberg BE; Nilsson OR; Wettre S Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190 [TBL] [Abstract][Full Text] [Related]
36. Treatment of moderate to severe hypertensive patients with an orally active converting-enzyme inhibitor. Prins EJ; Donker AJ; Hoorntje SJ; Leenen FH; van der Hem GK Proc Eur Dial Transplant Assoc; 1979; 16():603-9. PubMed ID: 232914 [TBL] [Abstract][Full Text] [Related]
37. Hormonal responses to long-term converting enzyme inhibition in hypertensive patients. Ogihara T; Maruyama A; Hata T; Mikami H; Nakamaru M; Naka T; Ohde H; Kumahara Y Clin Pharmacol Ther; 1981 Sep; 30(3):328-35. PubMed ID: 6268347 [TBL] [Abstract][Full Text] [Related]
38. Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity. Larochelle P; Genest J; Kuchel O; Boucher R; Gutkowska Y; McKinstry D Can Med Assoc J; 1979 Aug; 121(3):309-16. PubMed ID: 223756 [TBL] [Abstract][Full Text] [Related]
39. Influence of food on acute and chronic effects of captopril in essential hypertensive patients. Salvetti A; Pedrinelli R; Magagna A; Abdel-Haq B; Graziadei L; Taddei S; Stornello M J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S25-9. PubMed ID: 2580172 [TBL] [Abstract][Full Text] [Related]
40. Comparison of sublingual captopril and nifedipine in immediate treatment of hypertensive emergencies. A randomized, single-blind clinical trial. Angeli P; Chiesa M; Caregaro L; Merkel C; Sacerdoti D; Rondana M; Gatta A Arch Intern Med; 1991 Apr; 151(4):678-82. PubMed ID: 2012448 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]